Cardiovascular Business

Cardiovascular Business serves as a source for news, business insights, and technological advancements in the field of cardiovascular medicine. We concentrate on the economic aspects and business strategies that support leading clinical practices, interventional methods, surgical innovations, and information technologies. Additionally, we cover pharmaceuticals and related products that play a crucial role in establishing a successful integrated cardiovascular practice.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#313218

United States

#78645

Health/Health

#1692

Traffic sources

Monthly visitors

Articles

Quality of care for heart patients does not improve in first year of ACO participation

3 weeks ago | cardiovascularbusiness.com | Michael Walter

Outpatient cardiology practices that participate in an accountable care organization (ACO) as part of the Medicare Shared Savings Program (MSSP) do not experience immediate improvements in the quality of care they provide, according to new findings published in JAMA Cardiology.[1] “In 2012, the U.S. Centers for Medicare and Medicaid Services introduced the MSSP to lower cost and improve care quality across ambulatory practices by promoting care coordination, infrastructure investment and care...
Cardiologist begins term as ACC president with an eye on workforce issues, health equity and more

3 weeks ago | cardiovascularbusiness.com | Michael Walter

Christopher M. Kramer, MD, a longtime cardiologist and cardiac imaging specialist, has officially started his one-year term as the new American College of Cardiology (ACC) president. Kramer currently serves as a professor and chief of the cardiovascular division at the University of Virginia School of Medicine. He has been an ACC member for 35 years, serving in a variety of leadership roles.
Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology

3 weeks ago | cardiovascularbusiness.com | Michael Walter

Boston Scientific has finalized its acquisition of Bolt Medical, a California-based medical device company that specializes in intravascular lithotripsy (IVL) technology, just after the U.S. Food and Drug Administration (FDA) cleared Bolt Medical’s IVL system to be marketed and sold throughout the United States. Boston Scientific did not share the news in an official press release. It did, however, issue an update on the Bolt Medical acquisition on social media.
Early pregnancy blood pressure patterns tied to hypertension risk years later

3 weeks ago | cardiovascularbusiness.com | Dave Fornell

New research shows early-pregnancy blood pressure trajectories are strongly associated with new-onset hypertension years after pregnancy. This may help better stratify risk for targeted surveillance and early interventions, and improve the prediction of cardiovascular disease risk in women later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

3 weeks ago | cardiovascularbusiness.com | Dave Fornell

The Heart Rhythm Society (HRS) has established is own legislative advocacy group Heart Rhythm Advocates (HRA), which has begun operations in Washington, D.C., and is raising money for political activities. HRA will focus on advocating for the care of patients with heart rhythm disorders and the healthcare professionals that serve them.
Key takeaways from ACC.25: Advances in cardiovascular science

3 weeks ago | cardiovascularbusiness.com | Dave Fornell

The American College of Cardiology (ACC) 2025 features more than 50 late-breaking clinical trials and research presentations that will guide cardiology practice. To sort through these and pick out those with the most impact, Cardiovascular Business spoke with Hadley Wilson, MD, former ACC president and executive vice chair of Atrium Health Sanger Heart and Vascular Institute, to provided insights into what said are some of the key findings.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

3 weeks ago | cardiovascularbusiness.com | Michael Walter

At ACC.25, the annual conference of the American College of Cardiology, researchers presented two key follow-up studies focused on data from the EARLY TAVR trial. Each analysis provided additional insights about the potential benefits of treating asymptomatic severe aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) as opposed to clinical surveillance (CS).
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

3 weeks ago | cardiovascularbusiness.com | Michael Walter

Giving dapagliflozin to elderly heart failure patients who undergotranscatheter aortic valve replacement (TAVR) is associated with significant benefits, according to a late-breaking clinical trial presented at ACC.25, the annual conference of the American College of Cardiology.
American Heart Association program leads to substantial improvements in stroke care

3 weeks ago | cardiovascularbusiness.com | Dave Fornell

For two decades now, the American Heart Association (AHA) Get With The Guidelines-Stroke program has been focused on improving stroke care in the United States. Established in 2003, the initiative has contributed to a dramatic enhancement in adherence to evidence-based stroke treatment, leading to better patient outcomes, according to a recent study of data from 2003 to 2022 among stroke patients. To learn more, Cardiovascular Business spoke with Gregg C.
Bringing state-of-the-art healthcare to Florida heart patients

3 weeks ago | cardiovascularbusiness.com | Dave Fornell

The Naples Comprehensive Health (NCH) Rooney Heart Institute is making strides to transform its center into what it hopes will become a national-level cardiac care location in Southwest Florida. The institute is building a state-of-the-art heart hospital, investing in new technology and hiring notable doctors to establish itself as a premier destination for heart health. "We're building a heart center, a heart tower, and with it, we've recruited wonderful people.